{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:09:52Z","timestamp":1793390992294,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University of Pennsylvania Office of Nursing Research, Philadelphia, PA"},{"DOI":"10.13039\/100012400","name":"Sigma Theta Tau International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sigma Theta Tau - Xi Chapter"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtct.2025.05.013","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T12:26:09Z","timestamp":1747830369000},"page":"592.e1-592.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-Term Financial Toxicity After CAR T-Cell Therapy Among Patients in Remission and Their Caregivers"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-9929","authenticated-orcid":false,"given":"Lucy P.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2988-0633","authenticated-orcid":false,"given":"Ryan J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Difilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred L.","family":"Garfall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salimah H.","family":"Meghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.05.013_bib0001","unstructured":"National Cancer Institute. Financial Toxicity. NCI Dictionary of Cancer Terms. Accessed 2024. Available at: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/financial-toxicity. Accessed January 15, 2023."},{"issue":"3","key":"10.1016\/j.jtct.2025.05.013_bib0002","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2025.05.013_bib0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.soncn.2019.06.003","article-title":"Economic burden associated with cancer caregiving","volume":"35","author":"Bradley","year":"2019","journal-title":"Semin Oncol Nurs"},{"issue":"10","key":"10.1016\/j.jtct.2025.05.013_bib0004","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1007\/s12325-021-01872-x","article-title":"Health-related and economic burden among family caregivers of patients with acute myeloid leukemia or hematological malignancies","volume":"38","author":"Yucel","year":"2021","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.013_bib0005","first-page":"217","article-title":"Correlates of financial toxicity in adult cancer patients and their informal caregivers","volume":"30","author":"Sadigh","year":"2022","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2025.05.013_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.5897","article-title":"Financial toxicity and its association with health-related quality of life among partners of colorectal cancer survivors","volume":"6","author":"Ghazal","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jtct.2025.05.013_bib0007","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41409-020-0956-8","article-title":"Value and affordability of CAR T-cell therapy in the United States","volume":"55","author":"Fiorenza","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.013_bib0008","article-title":"Medicare braces for expanded use of high cost CAR T-cell therapy","author":"Lewis","year":"2021","journal-title":"Cell Gene"},{"key":"10.1016\/j.jtct.2025.05.013_bib0009","series-title":"ASGCT Submits Comment on CAR T-cell Therapy Coverage and Reimbursement","year":"2022"},{"key":"10.1016\/j.jtct.2025.05.013_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.620312","article-title":"Toxicities of chimeric antigen receptor t cell therapy in multiple myeloma: an overview of experience from clinical trials, pathophysiology, and management strategies. Review","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jtct.2025.05.013_bib0011","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1002\/ajh.25505","article-title":"Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy","volume":"94","author":"Chow","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2025.05.013_bib0012","article-title":"Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following CAR-T cell therapy: A Systematic Review","author":"Grant","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2025.05.013_bib0013","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1007\/s12325-021-01839-y","article-title":"Travel-related economic burden of chimeric antigen receptor T cell therapy administration by site of care","volume":"38","author":"Snyder","year":"2021","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.jtct.2025.05.013_bib0014","first-page":"358","article-title":"Socioeconomic and racial disparity in chimeric antigen receptor T cell therapy access","volume":"28","author":"Ahmed","year":"2022","journal-title":"Transplant Cell Ther Off Publ Am Soc Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.05.013_bib0015","unstructured":"Fitch K., Ferro C., Pittinger S. The cost burden of blood cancer care in Medicare. 2019:70. Available at: https:\/\/www.lls.org\/sites\/default\/files\/National\/USA\/Pdf\/Milliman-Cost-Of-Blood-Cancer-In-Medicare-20191016.pdf. Accessed March 4, 2024."},{"issue":"3","key":"10.1016\/j.jtct.2025.05.013_bib0016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1200\/OP.23.00243","article-title":"Financial toxicity and quality of life in patients undergoing stem-cell transplant evaluation: A single-center analysis","volume":"20","author":"Hussaini","year":"2024","journal-title":"JCO Oncol Pr"},{"key":"10.1016\/j.jtct.2025.05.013_bib0017","first-page":"70","article-title":"Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective","author":"Navas Huerga","year":"2024","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"10.1016\/j.jtct.2025.05.013_bib0018","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/bmt.2016.103","article-title":"Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study","volume":"51","author":"Denzen","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2025.05.013_bib0019","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-146032","article-title":"Worsening financial toxicity among patients receiving chimeric antigen receptor T-cell (CAR-T) therapy: a mixed methods longitudinal study","volume":"138","author":"Cusatis","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.05.013_bib0020","series-title":"Office of Disease Prevention and Health Promotion","year":"2022"},{"key":"10.1016\/j.jtct.2025.05.013_bib0021","doi-asserted-by":"crossref","unstructured":"Andersen L, Quinn, R., Difilippo, H., Garfall, A., Porter, D., Meghani, S., et al. Long-term quality of life, cognitive function, and symptom burden among chimeric antigen receptor T-cell recipients and associated cytokine release syndrome and neurotoxicity. JCO Oncol Pr. 2025; doi:https:\/\/doi.org\/10.1200\/OP-24-00823","DOI":"10.1200\/OP-24-00823"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.013_bib0022","first-page":"61","article-title":"Paying research participants: regulatory uncertainty, conceptual confusion, and a path forward","volume":"17","author":"Largent","year":"2017","journal-title":"Yale J Health Policy Law Ethics"},{"issue":"6","key":"10.1016\/j.jtct.2025.05.013_bib0023","first-page":"2329","article-title":"Distress and quality of life in patient and caregiver dyads facing stem cell transplant: identifying overlap and unique contributions","volume":"27","author":"Sannes","year":"2019","journal-title":"Support Care Cancer"},{"issue":"32","key":"10.1016\/j.jtct.2025.05.013_bib0024","doi-asserted-by":"crossref","first-page":"28167","DOI":"10.1007\/s12144-022-03860-y","article-title":"Patient-caregiver relationship in cancer fatigue and distress. A dyadic approach","volume":"42","author":"Taurisano","year":"2023","journal-title":"Curr Psychol"},{"issue":"3","key":"10.1016\/j.jtct.2025.05.013_bib0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/10428194.2016.1194983","article-title":"Dyadic coping of patients with hematologic malignancies and their partners and its relation to quality of life-a longitudinal study. Journal: article","volume":"58","author":"Ernst","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.jtct.2025.05.013_bib0026","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.6004\/jnccn.2020.7581","article-title":"A pilot study of a comprehensive financial navigation program in patients with cancer and caregivers","volume":"18","author":"Watabayashi","year":"2020","journal-title":"J Natl Compr Cancer Netw J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2025.05.013_bib0027","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3332\/ecancer.2021.1219","article-title":"Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study","volume":"15","author":"Dar","year":"2021","journal-title":"ecancermedicalscience"},{"issue":"2","key":"10.1016\/j.jtct.2025.05.013_bib0028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0041-1741074","article-title":"Translation and validation of COST - FACIT (Version 2) questionnaire into Hindi and Marathi to assess financial toxicity in indian cancer patients","volume":"11","author":"Joshi","year":"2022","journal-title":"South Asian J Cancer"},{"issue":"5","key":"10.1016\/j.jtct.2025.05.013_bib0029","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jval.2019.02.004","article-title":"PROMIS\u00ae adult health profiles: efficient short-form measures of seven health domains","volume":"22","author":"Cella","year":"2019","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.013_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41687-017-0003-8","article-title":"Two-item PROMIS\u00ae global physical and mental health scales","volume":"1","author":"Hays","year":"2017","journal-title":"J Patient-Rep Outcomes"},{"issue":"7","key":"10.1016\/j.jtct.2025.05.013_bib0031","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/arclin\/acaa128","article-title":"Normative reference values, reliability, and item-level symptom endorsement for the PROMIS\u00ae v2.0 cognitive function-short forms 4a, 6a and 8a","volume":"36","author":"Iverson","year":"2021","journal-title":"Arch Clin Neuropsychol"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2025.05.013_bib0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood-2020-134646","article-title":"Patient-reported outcomes at time of CAR-T cell therapy","volume":"136","author":"Mullane","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.05.013_bib0033","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bjh.18677","article-title":"Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy","volume":"201","author":"Wang","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2025.05.013_bib0034","series-title":"The University of Texax MD Anderson Cancer Center","article-title":"The M.D Anderson Symptom Inventory User Guide","author":"Cleeland","year":"2009"},{"issue":"10","key":"10.1016\/j.jtct.2025.05.013_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(15)00151-9","article-title":"Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Article","volume":"2","author":"Huntington","year":"2015","journal-title":"Lancet Haematol"},{"issue":"14","key":"10.1016\/j.jtct.2025.05.013_bib0036","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1200\/JCO.2011.37.9511","article-title":"Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis","volume":"30","author":"Shankaran","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2025.05.013_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2024.102519","article-title":"Financial toxicity of informal caregivers of colorectal cancer patients: a cross-sectional study","volume":"69","author":"Zhang","year":"2024","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"10.1016\/j.jtct.2025.05.013_bib0038","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/OP.23.00434","article-title":"Financial toxicity and health-related quality of life profile of patients with hematologic malignancies treated in a universal health care system","volume":"20","author":"Sparano","year":"2024","journal-title":"JCO Oncol Pr"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.013_bib0039","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12885-023-10580-4","article-title":"Associations of financial toxicity with symptoms and unplanned healthcare utilization among cancer patients taking oral chemotherapy at home: a prospective observational study","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.05.013_bib0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpainsymman.2018.12.003","article-title":"Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review","volume":"57","author":"Chan","year":"2019","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"10.1016\/j.jtct.2025.05.013_bib0041","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/0284186X.2023.2240008","article-title":"Perceived burden and need for support among caregivers of cancer patients","volume":"62","author":"Gjerset","year":"2023","journal-title":"Acta Oncol"},{"issue":"S19","key":"10.1016\/j.jtct.2025.05.013_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/alz.073133","article-title":"Financial toxicity in dementia caregiving","volume":"19","author":"Hart","year":"2023","journal-title":"Alzheimer's Dement"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725011972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725011972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:44:51Z","timestamp":1785548691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725011972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666636725011972"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.05.013","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Financial Toxicity After CAR T-Cell Therapy Among Patients in Remission and Their Caregivers","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}